Jon Congleton
2016 - Nivalis Therapeutics
In 2016, Jon Congleton earned a total compensation of $2.1M as Former President and Chief Executive Officer at Nivalis Therapeutics, a 39% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $225,000 |
|---|---|
| Option Awards | $1,348,250 |
| Salary | $450,000 |
| Other | $52,525 |
| Total | $2,075,775 |
Congleton received $1.3M in option awards, accounting for 65% of the total pay in 2016.
Congleton also received $225K in non-equity incentive plan, $450K in salary and $52.5K in other compensation.
Rankings
In 2016, Jon Congleton's compensation ranked 4,715th out of 14,075 executives tracked by ExecPay. In other words, Congleton earned more than 66.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,715 out of 14,075 | 67th |
Division Manufacturing | 1,681 out of 5,489 | 69th |
Major group Chemicals And Allied Products | 521 out of 1,895 | 73rd |
Industry group Drugs | 385 out of 1,538 | 75th |
Industry Pharmaceutical Preparations | 305 out of 1,176 | 74th |
Source: SEC filing on April 24, 2018.
Congleton's colleagues
We found four more compensation records of executives who worked with Jon Congleton at Nivalis Therapeutics in 2016.